| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Molecular and Cellular Biology, February 2007, p. 1394-1406, Vol. 27, No. 4
0270-7306/07/$08.00+0 doi:10.1128/MCB.00736-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Department of Cellular Biology, University of Georgia, Athens, Georgia 30602-2607
Received 27 April 2006/ Returned for modification 23 May 2006/ Accepted 27 November 2006
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The structure of the CUL4 complex varies based on the role of the complex component DDB1. DDB1 (damaged-DNA binding protein 1) was initially identified as a component of the DDB complex, which functions in nucleotide excision repair and is defective in individuals with xeroderma pigmentosum and Cockayne syndromes (10, 34). DDB1 can function as an adaptor to link SRSs to the core CUL4 complex. In humans, DDB1 binds a heterodimeric SRS comprised of human DET1 (hDET1) and hCOP1 to target the degradation of the c-Jun transcription factor (80). Human DDB1 also binds the V proteins of paramoxyviruses, which act as SRSs in the degradation of STAT proteins (41, 75). Other proteins that have been implicated as SRSs for CUL4 complexes include mammalian DDB2, which targets the ubiquitination of histones H3, histone H4, and the xerodosum pigmentosum protein XP-C; Schizosaccharomyces pombe Cdt2, which targets the degradation of the ribonucleotide reductase regulator Spd1; and mammalian CSA, which targets the degradation of the Cockayne syndrome protein CSB (20, 21, 44, 66, 79). However, there is also evidence that DDB1 can act as an SRS and bind substrates directly. Human DDB1 binds to Cdt1 to mediate Cdt1 degradation in response to a DNA damage checkpoint (26). In C. elegans, CUL-4 negatively regulates the Cdt1 ortholog, CDT-1, to prevent rereplication during S phase (84).
Maintaining genome integrity depends on the accurate replication of the genome during each cell division cycle. DNA replication is strictly regulated to ensure that origins of replication can initiate DNA synthesis only once per cell cycle. In eukaryotes, this regulation is focused on the assembly of prereplicative complexes prior to S phase. Prereplicative complexes form on origins through the sequential binding of key DNA replication proteins: the six-member origin recognition complex, the replication licensing factors Cdt1 and Cdc6, and the presumptive replicative helicase, the Mcm2-7 complex (5, 47). Cdt1 and Cdc6 are essential loading factors for the Mcm2-7 complex, and they are regulated to ensure that the Mcm2-7 complex cannot rebind origins that have already fired during S phase. In yeast and metazoa, Cdt1 and Cdc6 are removed from the nucleus during S phase by degradation or nuclear export, thereby ensuring that they are unable to reload the Mcm2-7 complex (5, 14, 47).
In fission yeast and metazoa, Cdt1 is regulated by proteolysis at the onset of S phase and in response to DNA damage (3, 24, 26, 36, 57, 59, 73, 84). Our laboratory has shown that in C. elegans, loss of CUL-4 leads to a failure to degrade CDT-1, which is associated with extensive DNA rereplication (84). In mammals and Drosophila, expression of Cdt1 to high levels induces limited DNA rereplication (73, 77).
It has been reported that in humans, the degradation of Cdt1 in response to DNA damage or S-phase entry is mediated by the SCFSkp2 E3 complex (36, 42). The binding of SCFSkp2 to Cdt1 is dependent on prior phosphorylation of Cdt1 by cyclin-dependent kinase (CDK)/cyclin complexes (46, 67). The CUL4 E3 complex has also been reported to be required for the DNA damage-induced degradation of Cdt1 in both human and Drosophila cells (24, 26). In Xenopus egg extracts, a CUL4/DDB1 complex is the predominant E3 for Cdt1 degradation during S phase, although a role for Skp2 has not been explicitly ruled out (3). More recent reports indicate that both CUL4/DDB1 and SCFSkp2 are required for the complete degradation of human Cdt1 in S phase, suggesting that in humans, both E3s target Cdt1 for degradation (58, 62). It is unclear to what extent the two pathways of Cdt1 degradation are evolutionarily conserved.
In this work, we characterize the loss-of-function phenotypes of the C. elegans orthologs of DDB1 and Skp2 and determine the extent to which they contribute to the degradation of CDT-1 in S phase. We find that ddb-1 mutants are nonviable due to defects in postembryonic cell divisions. The CUL-4/DDB-1 complex is required for CDT-1 degradation during S phase and for restraining DNA rereplication. DDB-1 physically associates with CDT-1, indicating that CDT-1 is a direct substrate of the CUL-4/DDB-1 complex. In contrast, the Skp2 ortholog, SKPT-1, is not required for viability and only exhibits an impenetrant defect in gonad migration. SKPT-1 provides no measurable contribution to the degradation of CDT-1 either in a wild-type or a ddb-1 mutant background.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Two-hybrid assay. Two-hybrid analysis was performed with the full-length ddb-1 gene in the pACTII (activation domain) vector and full-length cullin genes in the pAS2 (DNA binding domain) vector (Clontech). Transformation of the Saccharomyces cerevisiae strain pJ69-4A (29) was performed as described previously (30). Interaction in the two-hybrid system was tested by growth on both histidine- and adenine-deficient selective media.
Immunofluorescence. Affinity-purified polyclonal anti-CDT-1 and anti-CDK-inhibitor 1 (CKI-1) and monoclonal anti-CYE-1 (17C8) were as described previously (7, 15, 84). Anti-AJM-1 (MH27), which highlights gap junctions (37), was obtained from the Developmental Studies Hybridoma Bank. Anti-rabbit Alexa Fluor 488 (Molecular Probes) and anti-mouse rhodamine (Cappel) were used as secondary antibodies. DNA was stained with 1 µg/ml Hoechst 33258 dye. Immunofluorescence was performed using the "freeze-crack" method, as described previously (53). For analysis of CDT-1 expression in L1 larvae at set times after hatching, timed cohorts of newly hatched L1 larvae were collected at 15-min intervals and allowed to develop for the required length of time on plates containing OP50 bacteria as a food source, as previously described (84).
Microscopy. Animals were observed by differential interference contrast (DIC) and immunofluorescence microscopy using a Zeiss Axioskop microscope. Images were taken with a Hamamatsu ORCA-ER digital camera with Openlab, version 4.0.2, software (Improvision). Images were processed with Adobe Photoshop 7.0. Matched images were taken with the same exposure time and processed identically. Matched images of anti-CDT-1, anti-AJM-1, and 4',6'-diamidino-2-phenylindole (DAPI) staining (see Fig. 3B and 5) were deconvolved to equivalent extents to minimize background fluorescence using the multi-neighbor deconvolution program of Openlab.
|
|
Ectopic expression of CDT-1::GFP and Prnr-1::RFP. To generate extragenic transgenic lines, we microinjected into the strain PS3729 (which expresses AJM-1::GFP) N2 genomic DNA (200 µg/ml), the marker plasmid pRF4 containing rol-6(su1006) (5 µg/ml) (49), the S-phase marker plasmid pRED95.67/Prnr-1 (5 µg/ml), and either pPD95.75/Pwrt-2-cdt-1WT (5 µg/ml) or pPD95.75/Pwrt-2-cdt-1PIP(6A) (5 µg/ml). To create plasmid pPD95.75/Pwrt-2-cdt-1WT, we fused the wrt-2 promoter and cdt-1 genomic coding sequence using an overlap extension mutagenesis method (52). The fusion of wrt-2 promoter and cdt-1 was introduced into plasmid pPD95.75, which provides a C-terminal GFP fusion. For pPD95.75/Pwrt-2-cdt-1PIP(6A), site-directed mutation of six conserved amino acids in the proliferating cell nuclear antigen (PCNA)-interacting protein (PIP) box was introduced using an overlap extension PCR method with the following primer pairs (lowercase letters indicate altered nucleotides): CCGCATGCTTACGACGAATAATTTTATTGAATTTTG and GcagCAGCAGTCgcCGGAGTCTGGGACC and gcGACTGCTGctgCtGcCgcTgctAAGGTAAATTGGAGTTTGAAG and CTTCCACGAGATTCGGTC. Plasmid pRED95.67 was created by replacing the GFP cDNA sequence of pPD95.67 with red fluorescent protein (RFP) cDNA from plasmid pPD158.114. The rnr-1 promoter and simian virus 40 nuclear localization signal sequences, which came from pVT501, were introduced into SphI/AgeI sites of pRED95.67 to create plasmid pRED95.67/Prnr-1.
Transfection, immunoprecipitation, and immunoblot analysis. Human 293T cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (Gibco-BRL). For expression in 293T cells, full-length cDNA sequences of ddb-1 and cdt-1 were cloned into pCMV-Tag2 (Stratagene) and pEGFP-N1 (Clontech), respectively, and full-length cDNA sequences of skpt-1 and lin-23 were cloned into pcDNA3.1(+)/myc-His (Invitrogen). 293T cells were transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. After a 60-h incubation at 37°C, cells were lysed with NP-40 buffer containing 10 mM sodium phosphate (pH 7.2), 150 mM NaCl, 1% NP-40, 2 mM EDTA, complete protease inhibitors cocktail (Roche), Ser/Thr and Tyr phosphatase inhibitors (Upstate), and 50 µM N-acetyl-L-leucinyl-L-leucinal-L-norleucinal (Sigma). To minimize proteasome-mediated degradation, transfected cells were treated with 50 µM N-acetyl-L-leucinyl-L-leucinal-L-norleucinal 10 h before harvest. The primary antibodies used in immunoprecipitation and Western detection were anti-MYC (9E10; Covance), anti-FLAG (M2; Sigma), rabbit polyclonal anti-MYC tag (Bethyl Laboratory), and anti-CDT-1 (84). The secondary antibodies used were anti-rabbit-horseradish peroxidase (Pierce) and anti-mouse-horseradish peroxidase (GE Healthcare and Pierce). Western blots were visualized using the Advanced ECL chemiluminescence system (GE Healthcare).
In vitro binding. Plasmid pGEX-2T/cdt-1 contains the full-length cdt-1 gene in the pGEX-2T vector (64). pGEX-2T/cdt-1 was expressed in the E. coli strain BL21cp. The glutathione S-transferase (GST)-tagged CDT-1 protein was solubilized and purified using a modification of a previously described method (17). Briefly, bacteria were induced with 1 mM isopropyl-ß-D-thiogalactopyranoside for 4 h at 37°C, pelleted, and resuspended in STE medium (10 mM Tris, pH 8.0, 150 mM NaCl, and 1 mM EDTA) containing 100 µg/ml of lysozyme. N-Laurylsarcosine (sarcosyl) was added to a final concentration 0.5% to solubilize the recombinant CDT-1 proteins. After a 1-h incubation, Triton X-100 was added to 2%, and GST-CDT-1 protein was purified with glutathione-Sepharose 4 Fast Flow beads (GE Healthcare), according to the manufacturer's instructions. To phosphorylate GST-CDT-1 on CDK sites, the purified protein was incubated with recombinant human cdk1/cyclin B (Upstate) in phosphorylation buffer (40 mM Tris, pH 7.4, 5 mM MgCl2, 1 mM dithiothreitol, 500 µM ATP, and 1 µM okadaic acid) for 90 min at 30°C. 35S-labeled FLAG-DDB-1 and SKPT-1-MYC proteins encoded by the pCMV-Tag2/ddb-1 and pcDNA3.1(+)/myc-His/skpt-1 constructs, respectively, were translated using a TNT T7/T3 Coupled Wheat Germ Extract System (Promega). 35S-labeled FLAG-DDB-1 protein was further purified through affinity binding to anti-FLAG M2 agarose (Sigma) and elution with FLAG peptide (Sigma). Purified GST, GST-CDT-1, or phosphorylated GST-CDT-1 proteins were incubated with 35S-labeled FLAG-DDB-1 or SKPT-1-MYC for 30 min on ice. Glutathione-Sepharose 4 Fast Flow beads were added and incubated for an additional 30 min with rotation. After a washing step, proteins associated with the beads were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by autoradiography. Ten percent of the 35S-labeled FLAG-DDB-1 or SKPT-1-MYC proteins that were used for each binding reaction was loaded in input lanes.
| RESULTS |
|---|
|
|
|---|
|
|
ddb-1 loss-of-function phenotypes. We have characterized a ddb-1 mutant deletion allele, ddb-1(tm1769) that was isolated by the National Bioresource Project, Japan. The tm1769 allele is a deletion of 540 bp that removes the promoter region and exons 1 and 2 of the ddb-1 gene; it is therefore expected to be a null allele (Fig. 1A). ddb-1(tm1769) is recessive, and homozygotes are nonviable, and thus the allele is maintained as a heterozygous strain. Homozygous ddb-1(tm1769) mutant progeny from heterozygous parents exhibit normal embryogenesis. Approximately 15% (7/47) of ddb-1(tm1769) homozygotes arrest at the L2 or L3 stages, while the remaining 85% become sterile adults with a protruding vulva phenotype (see Fig. 4D). The timing of larval development is significantly slower for homozygous ddb-1(tm1769) mutants than for wild-type larvae (81.3 ± 5.6 h versus 64.8 ± 3.9 h from laid eggs to adult at 20°C; n = 10 for each group; P < 1 x 106).
|
Loss of DDB-1 induces DNA rereplication. Loss of cul-4 causes proliferating blast cells to undergo DNA rereplication, resulting in dramatically enlarged nuclei and increased DNA content (84). We observed that arrested ddb-1(tm1769) homozygotes have similarly enlarged seam cells (Fig. 3A). Other blast cell lineages also exhibit increased size; however, nonproliferating cells are not affected (data not shown). The enlarged ddb-1 mutant cells show markedly increased DNA levels (25.9 ± 15.4 versus 2.0 ± 0.2 C in wild type; n = 20 for each group; 1 C is equivalent to 1n DNA content; P < 1 x 107) (Fig. 3B), suggesting that DDB-1 prevents DNA rereplication, similar to CUL-4. Enlarged seam cells are also observed in the 85% of ddb-1 homozygotes that develop to the adult stage.
In our previous study, loss of cul-4 function was derived solely from RNAi depletion, as a mutant allele was not available (84). We have now obtained a cul-4 mutant allele, gk434, which is a deletion of the promoter region and exons 1 and 2 and is, therefore, expected to be a null allele (Fig. 1B). The cul-4(gk434) allele is recessive and homozygotes are nonviable. cul-4(gk434) homozygotes uniformly arrest at the L2 stage with enlarged blast cells that have increased DNA content, similar to cul-4(RNAi) and ddb-1(RNAi) larvae (Fig. 3A). The physical interaction between DDB-1 and CUL-4 and their largely indistinguishable mutant phenotypes are consistent with a CUL-4/DDB-1 complex mediating the known CUL-4 functions.
Vulval and germ line development is defective in ddb-1-deficient animals. To investigate whether ddb-1 mutants that develop to the adult stage have defects associated with rereplication, we focused on the late-dividing vulval lineage. The vulva is composed of 22 cells that are generated from three progenitor VPCs during the L3 stage (68). ddb-1(tm1769) homozygotes have a significantly reduced number of vulval cells (11.0 ± 1.2; n = 23 versus 22 in wild type) (68), and these cells are enlarged (Fig. 4A and B). ddb-1 mutants exhibit abnormal vulval morphology during larval development and protruding vulvae in adults (Fig. 4A to D), similar to defects associated with inadequate vulval cell numbers (11, 63). DNA levels in ddb-1 mutant vulval cells are significantly increased (7.2 ± 1.4 versus 2.1 ± 0.4 C in wild type; n = 14 for each group; P < 1 x 109), suggesting that the enlargement of vulval cells results from DNA rereplication (Fig. 4I to L). Somatic gonadal cells also divide during the L3 stage, and we observed that these cells are also larger and contain increased DNA levels (Fig. 4A, B, and I to L).
Germ cells in ddb-1(tm1769) mutants exhibit vacuoles and corrupted cell and nuclear morphology during the L4 stage and often undergo necrosis in older adults (Fig. 4E to H; also data not shown). Spermatogenesis is observed in ddb-1(tm1769) mutants, and oogenesis occurs infrequently, suggesting that meiotic entry per se is not defective (Fig. 4E, F, I, and J). Similar germ cell defects are observed when larvae are fed bacteria expressing cul-4 dsRNA, indicating that CUL-4 is also required for germ cell viability (data not shown). There is, however, no clear link between these germ line defects and DNA replication. ddb-1 mutant germ cells do not have DNA levels higher than the normal cell cycle range of 2n to 4n: the DNA level in wild-type germ cells is 2.2 ± 0.4 C while ddb-1(tm1769) germ cells have 2.6 ± 0.6 C (n = 19 for each group). This suggests that DDB-1 is required for germ cell viability independently of its role in regulating DNA replication.
DDB-1 is required for CDT-1 degradation during S phase. In fission yeast and metazoa, the essential DNA replication licensing factor CDT-1 is degraded upon entry into S phase to ensure that DNA rereplication does not occur (5, 47). In C. elegans, CUL-4 is required for CDT-1 degradation during S phase (84). We asked whether DDB-1 is similarly required for CDT-1 degradation during S phase. The V1 to V6 seam cells enter S phase at approximately 120 min posthatching at 20°C (84). Immunofluorescence staining with anti-CDT-1 antibody shows that CDT-1 is present in late G1 phase nuclei (90 to 110 min posthatching) in both wild-type and ddb-1(RNAi) seam cells (Fig. 5A and B). In wild-type larvae, the level of CDT-1 protein abruptly decreases as seam cells enter S phase, and CDT-1 is not detected at 180 to 200 min posthatching (Fig. 5A) (84). In ddb-1 RNAi larvae, however, the CDT-1 protein levels do not drop after cells enter S phase but, instead, remain elevated even at 180 to 200 min posthatching, indicating that DDB-1 is required for CDT-1 degradation during S phase (Fig. 5B).
We observed a similar requirement for DDB-1 in the degradation of a CDT-1::GFP fusion protein during S phase (Fig. 6B and C). CDT-1::GFP was expressed in a strain that contains AJM-1::GFP to visualize seam cell boundaries and an S-phase marker transgene, in which RFP was expressed from the ribonucleotide reductase promoter (Prnr-1::RFP). The CDT-1::GFP signal is much higher relative to the background compared to anti-CDT-1 immunofluorescence; and it is clearly apparent that CDT-1::GFP is degraded during S phase rather than undergoing redistribution to the cytoplasm (Fig. 6B). The observed requirement of DDB-1 for CDT-1 degradation during S phase is similar to that observed for CUL-4 (84), strongly suggesting that DDB-1 functions with CUL-4 to negatively regulate DNA replication in vivo.
|
In vertebrates and Drosophila, Cdt1 is also inhibited by binding to geminin (51, 61, 71, 81). In C. elegans, RNAi depletion of the geminin homolog gmn-1 is associated with the enlargement of some germ cell nuclei, which led to the proposal that GMN-1 prevents rereplication in germ cells (82). We investigated the possibility that ddb-1 mutant germ cells failed to undergo rereplication because of redundant regulation by GMN-1. We analyzed a gmn-1(tm2212) allele that deletes 236 bp of the gmn-1 locus, including conserved residues that are required for binding CDT-1 (38). gmn-1(tm2212) is recessive and exhibits maternal-effect sterility: gmn-1(tm2212) homozygous progeny of heterozygotes are viable, but their progeny (which lack maternal product) are nonviable or sterile (data not shown). We observed that a subset of germ cells is enlarged in gmn-1(tm2212) homozygotes, similar to what was previously reported for gmn-1 RNAi (82). Unexpectedly, DAPI staining of the gmn-1(tm2212) mutant gonad indicated that DNA levels are not increased in the enlarged germ cells, suggesting that rereplication is not occurring (data not shown). Inactivation of both DDB-1 and GMN-1 [by ddb-1 RNAi depletion of gmn-1(tm2212) homozygotes] did not significantly increase germ cell DNA levels relative to that of ddb-1(RNAi) animals (data not shown). Further, we did not observe marked differences in the level of CDT-1 within the mitotic germ cells of wild type or ddb-1(tm1769) mutants (data not shown). This suggests that a CDT-1-independent pathway prevents rereplication in germ cells.
DDB-1 physically interacts with CDT-1. DDB1 has been observed to function in the CUL4 E3 complex either as the SRS, which directly binds to substrates, or as an adaptor that links the SRS to the complex (26, 75, 80). To determine whether DDB-1 can interact with CDT-1, we expressed the proteins in human 293T cells. We observed that DDB-1 and CDT-1 reciprocally coimmunoprecipitated each other (Fig. 7A). We also tested for interaction between DDB-1 and CDT-1 using an in vitro system. 35S-labeled FLAG-tagged DDB-1, which was in vitro translated using a wheat germ extract and then was affinity purified, specifically bound to purified, recombinant GST-tagged CDT-1 in vitro (Fig. 7C). The interaction between DDB-1 and CDT-1 in both systems supports the proposal that DDB-1 can physically interact with CDT-1.
|
CUL-4/DDB-1 negatively regulates CKI-1 and CYE-1 protein levels. Recently, it has been reported that CUL4/DDB1 promotes the degradation of the CDK-inhibitor p27KIP1 and cyclin E in humans and Drosophila (6, 25, 40). To determine whether C. elegans CUL-4/DDB-1 negatively regulates the CIP/KIP-family member CKI-1 and the cyclin E ortholog CYE-1, we analyzed CKI-1 and CYE-1 levels in ddb-1(RNAi)-arrested larvae using immunofluorescence. Staining with anti-CKI-1 and anti-CYE-1 antibodies showed accumulation of both proteins in the enlarged seam cell nuclei of ddb-1(RNAi)-arrested larvae (Fig. 3C). This suggests either that the CUL-4/DDB-1 complex directly regulates CKI-1 and CYE-1 or that the elevated levels are a secondary consequence of the S-phase arrest/rereplication.
We tested whether CKI-1 accumulation contributes to the rereplication. RNAi was used to deplete CKI-1 in cul-4(gk434)/mIn1 hermaphrodite adults. We found that cki-1 RNAi did not suppress the L2 stage arrest of cul-4 mutants. However, the size of seam cell nuclei in cki-1(RNAi) cul-4(gk434) larvae was reduced approximately threefold relative to cul-4(gk434) larvae (36.2 ± 14.0 µm2 versus 113.5 ± 52.7 µm2 [n = 20 for each group], respectively; wild type is 11.8 ± 0.7 µm2; n = 6). The seam cell DNA level was reduced
6.7-fold [3.8 ± 1.7 C for cki-1(RNAi) cul-4(gk434) versus 25.6 ± 11.3 C for cul-4(gk434); n = 6 each]. This indicates that cki-1 RNAi depletion suppresses the rereplication phenotype of cul-4 mutants (Fig. 3A and B). Significantly, the cki-1(RNAi) cul-4(gk434) larvae still accumulated CDT-1 protein in seam cells (Fig. 3B), indicating that CKI-1 is not required for the accumulation of CDT-1 and that CDT-1 accumulation is not sufficient to induce extensive rereplication. We could not perform a similar test to determine if CYE-1 is required for rereplication, because cye-1 RNAi produces an embryonic arrest that precludes analysis of larval cells (13).
C. elegans Skp2 is not required for CDT-1 degradation during S phase. It has been proposed that the human SCFSkp2 ubiquitin ligase targets Cdt1 for degradation during S phase (42, 46, 58, 67). C. elegans has only one Skp2 ortholog, skpt-1 (Skp-two related protein) (Fig. 1C). The SKPT-1 protein has 28% sequence identity with human Skp2, and reciprocal BLAST analysis provides matches with E values of 1024. To investigate the function of SKPT-1 in C. elegans, we analyzed skpt-1(ok851) mutants. The skpt-1(ok851) allele deletes exons 2 and 3 and parts of exons 1 and 4, with the resulting exon 1-exon 4 fusion creating a premature truncation, strongly suggesting that it is a null allele. skpt-1(ok851) homozygotes are viable and produce similar numbers of eggs compared to wild type (277 ± 26 versus 288 ± 36 eggs; n = 6 and 10, respectively). skpt-1(ok851) homozygotes appear overtly wild type, with the exception of a low-penetrance gonad mismigration phenotype, in which 7% (8/113) of skpt-1(ok851) mutants exhibit an improper trajectory of one gonad arm (Fig. 8A). skpt-1 RNAi produces a similar level of gonad migration defects (7%; 13/180) (H. Jin and E. T. Kipreos, unpublished observation). A strain heterozygous for the skpt-1(ok851) allele and a deficiency (sDf121) that eliminates the skpt-1 locus [so that the heterozygotes have only one copy of the skpt-1(ok851) allele] also has a 7% (9/132) level of gonad mismigration. The observation that one copy of the skpt-1(ok851) allele gives the same phenotype as two copies provides genetic evidence that the skpt-1(ok851) is a null allele.
|
To test whether C. elegans SKPT-1 can bind CDT-1, we analyzed their interaction in 293T cells. Reciprocal immunoprecipitations of CDT-1-GFP and SKPT-1-MYC pulled down only very low levels of the other protein. The extent of interaction between CDT-1 and SKPT-1 was not higher than that between CDT-1 and a nonspecific F-box protein, LIN-23 (Fig. 7B). In contrast, the interaction of CDT-1 and DDB-1 was considerably stronger than the interaction between DDB-1 and LIN-23 (Fig. 7A). In an in vitro binding assay, the interaction between GST-CDT-1 and in vitro translated DDB-1 was 7.3-fold higher than between GST-CDT-1 and in vitro translated SKPT-1 (Fig. 7C). Skp2 recognizes only CDK-phosphorylated substrates (60). Significantly, phosphorylation of CDT-1 by CDK did not increase interaction with SKPT-1 (Fig. 7C), further suggesting that it is not a real substrate of SKPT-1. Taken together with the failure of SKPT-1 to regulate CDT-1 levels in vivo, these results suggest that SKPT-1 does not contribute significantly to the degradation of CDT-1.
| DISCUSSION |
|---|
|
|
|---|
DDB-1 is required for viability and shares mutant phenotypes with cul-4. ddb-1 RNAi produces an L2-stage larval arrest similar to that observed in cul-4 mutants. The arrested ddb-1(RNAi) larvae exhibit signs of rereplication with large, polyploid blast cells, similar to what we have previously described for cul-4(RNAi) larvae (84) and now observe in cul-4 mutants. We showed that DDB-1 interacts specifically with CUL-4 but not with other C. elegans cullins. This physical interaction, coupled with their similar mutant phenotypes, strongly suggests that CUL-4 regulates DNA replication solely through a CUL-4/DDB-1 complex.
We had previously observed rereplication in a wide range of somatic blast cells in arrested cul-4(RNAi) larvae (84). Our current data suggest that CUL-4/DDB-1 is also required to restrain DNA replication in later somatic cell divisions. In ddb-1 mutants, early larval cell divisions occur normally (apparently due to rescue by maternal product), but mutant phenotypes are observed in later larval stages. ddb-1 mutants exhibit cell division failures associated with increased DNA levels in the late-dividing vulva and the somatic gonad lineages. Interestingly, we did not observe rereplication defects in germ cells or embryos upon loss of ddb-1 or cul-4 function. However, germ cells in ddb-1 mutants or cul-4(RNAi) animals have defects in proliferation and aberrant morphology, suggesting that the CUL-4/DDB-1 complex plays a critical role in these cells independently of restraining DNA replication.
It is possible that a redundant regulatory mechanism could be preventing rereplication in ddb-1 mutant germ cells. In vertebrates and Drosophila, Cdt1 is inhibited by binding to geminin (51, 61, 71, 81). The C. elegans geminin ortholog, GMN-1, has been shown to bind CDT-1 in both the two-hybrid system and in vitro (82). gmn-1 RNAi was reported to produce enlarged germ cells (82). We observed that gmn-1 deletion allele homozygotes have similar, large germ cells, but these enlarged cells did not contain increased DNA levels. Further, there was no increase in DNA content upon ddb-1 RNAi depletion of gmn-1 mutants. Therefore, the failure to observe rereplication in cul-4 or ddb-1 mutant germ cells is not attributable to redundant regulation by geminin.
Mammalian and Drosophila CUL4 promote the degradation of cyclin E and the CKIs p27KIP1 and Dacapo, respectively (25, 40). We observed that levels of both CKI-1 and cyclin E accumulate in the rereplicating blast cells of ddb-1(RNAi) larvae. Significantly, cki-1 RNAi depletion was able to rescue the rereplication phenotype of cul-4 mutants, indicating that CKI-1 is essential for rereplication to occur. The role that CKI-1 plays in promoting rereplication is currently unknown but may involve arresting the cells in S phase. C. elegans cul-4 mutant rereplicating cells are characterized by both an S-phase arrest and dramatic increases in ploidy (84); however, an S-phase arrest is not observed in rereplicating mammalian cells, which have only limited increases in ploidy (77). It is significant that cki-1 RNAi did not rescue the L2-stage developmental arrest associated with inactivation of CUL-4 or DDB-1, indicating that the developmental arrest is not linked to rereplication or CKI-1 accumulation.
CDT-1 is a direct target of CUL-4/DDB-1. We had previously shown that CUL-4 is required for the degradation of CDT-1 in S phase (84). We also reported that the deletion of one copy of genomic cdt-1 can significantly suppress the rereplication phenotype of cul-4(RNAi) larvae, suggesting that CDT-1 perdurance is a decisive factor in causing the rereplication. In this study, we found that CDT-1 is not degraded during S phase in ddb-1 mutants, strongly supporting the proposal that CUL-4 mediates CDT-1 degradation through a conserved CUL-4/DDB-1 complex.
The crystal structure of DDB1 reveals a multidomain structure consisting of three ß-propellers that have multiple potential protein-protein interaction sites that could, in principle, allow DDB1 to bind to many substrates or SRSs (1, 41). A number of proteins have been identified as DDB1 interactors in the context of the CUL4 complex (1, 20, 21, 32, 44, 66, 75, 80), suggesting that in many instances DDB1 functions as an adaptor to bind SRSs. Two proteins that bind mammalian DDB1 (hDET1-COP1 and paramoxyvirus V proteins) have been shown to function as SRSs that directly bind the substrate (75, 80). In more cases, potential SRSs have been linked to specific CUL4/DDB1 functions (20, 21, 23, 32, 44, 66, 79).
In humans, Xenopus, and Drosophila, CDT2/L2DTL binds to DDB1 and has been shown to be required for CDT1 degradation in response to DNA damage (23, 32). It is possible that CDT2/L2DTL is the SRS that binds CDT1 to the complex. However, this has not yet been completely established, as there is no report that CDT2/L2DTL can bind CDT1 directly. Another possibility is that CDT2/L2DTL is a cofactor for the CUL4/DDB1 complex. A well-studied cofactor for a cullin-RING complex is Cks1, which facilitates the binding of the substrate, p27Kip1, to the SCF complex SRS Skp2 (18, 65). Intriguingly, in the absence of CDT2/L2DTL, DDB1 binding to CUL4 in human cells is significantly reduced (23), suggesting that CDT2/L2DTL may regulate the formation of the CUL4/DDB1 complex.
We observed that C. elegans DDB-1 and CDT-1 can physically associate with each other when coexpressed in 293T cells and that in vitro translated DDB-1, made with a wheat germ extract, binds to bacterially produced recombinant GST-CDT-1. We found that CDK-mediated phosphorylation of CDT-1 does not improve the efficiency of in vitro binding to DDB-1, suggesting that CDT-1 degradation does not require prior phosphorylation. We cannot conclude that CDT-1 binds directly to DDB-1, as it is conceivable that a human or wheat protein bridges the two proteins in the 293T cell and wheat extract systems, respectively. We have been unable to isolate soluble recombinant DDB-1 protein, which has precluded a direct test of this question. However, purified human CDT1 has been shown to bind directly to purified human DDB1 (26), indicating that in humans, the two proteins can interact directly. Our data in two different expression systems are consistent with this result.
The C. elegans Skp2 homolog is not required for CDT-1 degradation. It has been reported that the human SCFSkp2 E3 complex targets Cdt1 for degradation and that depletion of Skp2 by treatment with small interfering RNA increases Cdt1 levels, particularly in S phase (42). SCFSkp2 binds substrates that are phosphorylated by CDK/cyclin kinases, and the mutation of CDK phosphorylation sites on Cdt1 has been reported to partially stabilize Cdt1 in S phase (46, 67). In contradiction, two other studies report that mutation of CDK phosphorylation sites on Cdt1 does not affect S-phase degradation (58, 72). Recently, it has been reported that both SCFSkp2 and CUL4/DDB1 E3 ligases are redundantly required for the complete degradation of Cdt1 in S phase (58, 62). Taken together, these results suggest that in humans, both SCFSkp2 and CUL4/DDB1 E3 ligases contribute to Cdt1 degradation.
One report has indicated that human Skp2 can coimmunoprecipitate CUL4/DDB1 and that Skp2 is essential for CUL4/DDB1-mediated degradation of the CKI p27KIP1 (6). This work suggested that Skp2 can function as an SRS for the CUL4 complex. Our observation that CKI-1 accumulates in the enlarged seam cells of ddb-1(RNAi) larvae suggests that C. elegans CUL-4/DDB-1 negatively regulates a CKI. However, C. elegans SKPT-1 and DDB-1 do not appear to interact in the 293T system beyond low background levels that are also seen between DDB-1 and the nonspecific F-box protein LIN-23 (data not shown).
We have characterized a skpt-1 deletion allele, which is a null by genetic criteria. skpt-1 mutants appear wild type with the exception of an impenetrant gonad mismigration phenotype. Gonad migration is an active process in which the distal tip cell migrates in response to extracellular guidance cues and leads the developing gonad into its final shape (39). It is presently unclear whether SKPT-1 functions cell autonomously in the distal tip cell or non-cell autonomously in the surrounding tissues. However, since 93% of skpt-1 homozygous mutants have a normal gonad migration pattern, SKPT-1 does not appear to have a major, nonredundant role in this process.
We have not observed any role for SKPT-1 in the S-phase degradation of CDT-1. In homozygous skpt-1 mutant larvae, CDT-1 is degraded as cells enter S phase with the same kinetics as in wild type, indicating that SKPT-1 is not required for CDT-1 degradation. The simultaneous inactivation of DDB-1 and SKPT-1 did not increase the size of rereplicating cells, their DNA content, or CDT-1 levels. This suggests that SKPT-1 has no discernible redundant function with DDB-1 to degrade CDT-1. Coimmunoprecipitation assays in 293T cells and in vitro binding studies suggest that SKPT-1 does not interact specifically with CDT-1, as the weak interaction observed is not higher than nonspecific interaction between LIN-23 and CDT-1.
It is an open question to what extent Skp2-dependent Cdt1 degradation is conserved across phyla or even among species of the same evolutionary class. The degradation of Cdt1 by Skp2 has only been reported in human cells. Small interfering RNA depletion of human Skp2 produces an approximately threefold increase in the level of Cdt1 (42, 58). In contrast, depletion of Skp2 in mouse cells has no effect on Cdt1 levels (56, 58). Human Skp2 has been reported to degrade a host of proteins, including Cdt1, Orc1, p27KIP1, p21CIP1, cyclin E, cyclin D, cyclin A, c-Myc, b-Myb, p130, E2F-1, p57, MKP-1, RAG-2, FOXO1, and possibly Cdk9, although this has been disputed (4, 8, 9, 19, 28, 31, 43, 48, 50, 69, 74, 78, 83). Nevertheless, Skp2/ mice are completely viable and fertile (55). Skp2/ mice exhibit a minor defect of polyploidy and extra centrosomes in the cells of a few tissues, but this is attributable to a failure of those cells to enter mitosis due to an inability to degrade p27KIP1 (54, 56). The lack of phenotypes associated with a failure to degrade other substrates suggests either that many Skp2 functions are not conserved between humans and mice or that mammalian Skp2 functions are largely redundant with other degradation pathways. Our findings demonstrate that Skp2-mediated degradation of Cdt1 is not conserved in nematodes, thereby highlighting the question of the pathway's conservation in other metazoa.
Overall, our study indicates that the requirement for two distinct ubiquitin ligases to degrade CDT-1 is not conserved in C. elegans; rather, CUL-4/DDB-1 is the paramount E3 for CDT-1 degradation during S phase. The conservation between nematodes and humans in the degradation of the replication licensing factor CDT-1 by a CUL4/DDB1 complex suggests that this is an ancient pathway for regulating the extent of DNA replication.
| ACKNOWLEDGMENTS |
|---|
This work was supported by grant R01 GM055297 from the National Institute of General Medical Sciences (NIH).
| FOOTNOTES |
|---|
Published ahead of print on 4 December 2006. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Arias, E. E., and J. C. Walter. 2006. PCNA functions as a molecular platform to trigger Cdt1 destruction and prevent re-replication. Nat. Cell Biol. 8:84-90.[CrossRef][Medline]
3. Arias, E. E., and J. C. Walter. 2005. Replication-dependent destruction of Cdt1 limits DNA replication to a single round per cell cycle in Xenopus egg extracts. Genes Dev. 19:114-126.
4. Bhattacharya, S., J. Garriga, J. Calbo, T. Yong, D. S. Haines, and X. Grana. 2003. SKP2 associates with p130 and accelerates p130 ubiquitylation and degradation in human cells. Oncogene 22:2443-2451.[CrossRef][Medline]
5. Blow, J. J., and A. Dutta. 2005. Preventing re-replication of chromosomal DNA. Nat. Rev. Mol. Cell Biol. 6:476-486.[CrossRef][Medline]
6. Bondar, T., A. Kalinina, L. Khair, D. Kopanja, A. Nag, S. Bagchi, and P. Raychaudhuri. 2006. Cul4A and DDB1 associate with Skp2 to target p27Kip1 for proteolysis involving the COP9 signalosome. Mol. Cell. Biol. 26:2531-2539.
7. Brodigan, T. M., J. Liu, M. Park, E. T. Kipreos, and M. Krause. 2003. Cyclin E expression during development in Caenorhabditis elegans. Dev. Biol. 254:102-115.[CrossRef][Medline]
8. Carrano, A. C., E. Eytan, A. Hershko, and M. Pagano. 1999. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1:193-199.[CrossRef][Medline]
9. Charrasse, S., I. Carena, V. Brondani, K. H. Klempnauer, and S. Ferrari. 2000. Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCF(p45Skp2) pathway. Oncogene 19:2986-2995.[CrossRef][Medline]
10. Chu, G., and E. Chang. 1988. Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA. Science 242:564-567.
11. Eisenmann, D. M., and S. K. Kim. 2000. Protruding vulva mutants identify novel loci and Wnt signaling factors that function during Caenorhabditis elegans vulva development. Genetics 156:1097-1116.
12. Euling, S., and V. Ambros. 1996. Heterochronic genes control cell cycle progress and developmental competence of C. elegans vulva precursor cells. Cell 84:667-676.[CrossRef][Medline]
13. Fay, D. S., and M. Han. 2000. Mutations in cye-1, a Caenorhabditis elegans cyclin E homolog, reveal coordination between cell-cycle control and vulval development. Development 127:4049-4060.[Abstract]
14. Feng, H., and E. T. Kipreos. 2003. Preventing DNA re-replication-divergent safeguards in yeast and metazoa. Cell Cycle 2:431-434.[Medline]
15. Feng, H., W. Zhong, G. Punkosdy, S. Gu, L. Zhou, E. K. Seabolt, and E. T. Kipreos. 1999. CUL-2 is required for the G1-to-S-phase transition and mitotic chromosome condensation in Caenorhabditis elegans. Nat. Cell Biol. 1:486-492.[CrossRef][Medline]
16. Flemming, A. J., Z. Z. Shen, A. Cunha, S. W. Emmons, and A. M. Leroi. 2000. Somatic polyploidization and cellular proliferation drive body size evolution in nematodes. Proc. Natl. Acad. Sci. USA 97:5285-5290.
17. Frangioni, J. V., and B. G. Neel. 1993. Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. Anal. Biochem. 210:179-187.[CrossRef][Medline]
18. Ganoth, D., G. Bornstein, T. K. Ko, B. Larsen, M. Tyers, M. Pagano, and A. Hershko. 2001. The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. Nat. Cell Biol. 3:321-324.[CrossRef][Medline]
19. Garriga, J., S. Bhattacharya, J. Calbo, R. M. Marshall, M. Truongcao, D. S. Haines, and X. Grana. 2003. CDK9 is constitutively expressed throughout the cell cycle, and its steady-state expression is independent of SKP2. Mol. Cell. Biol. 23:5165-5173.
20. Groisman, R., I. Kuraoka, O. Chevallier, N. Gaye, T. Magnaldo, K. Tanaka, A. F. Kisselev, A. Harel-Bellan, and Y. Nakatani. 2006. CSA-dependent degradation of CSB by the ubiquitin-proteasome pathway establishes a link between complementation factors of the Cockayne syndrome. Genes Dev. 20:1429-1434.
21. Groisman, R., J. Polanowska, I. Kuraoka, J. Sawada, M. Saijo, R. Drapkin, A. F. Kisselev, K. Tanaka, and Y. Nakatani. 2003. The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell 113:357-367.[CrossRef][Medline]
22. Hedgecock, E. M., and J. G. White. 1985. Polyploid tissues in the nematode Caenorhabditis elegans. Dev. Biol. 107:128-133.[CrossRef][Medline]
23. Higa, L. A., D. Banks, M. Wu, R. Kobayashi, H. Sun, and H. Zhang. 2006. L2DTL/CDT2 interacts with the CUL4/DDB1 complex and PCNA and regulates CDT1 proteolysis in response to DNA damage. Cell Cycle 5:1675-1680.[Medline]
24. Higa, L. A., I. S. Mihaylov, D. P. Banks, J. Zheng, and H. Zhang. 2003. Radiation-mediated proteolysis of CDT1 by CUL4-ROC1 and CSN complexes constitutes a new checkpoint. Nat. Cell Biol. 5:1008-1015.[CrossRef][Medline]
25. Higa, L. A., X. Yang, J. Zheng, D. Banks, M. Wu, P. Ghosh, H. Sun, and H. Zhang. 2006. Involvement of CUL4 ubiquitin E3 ligases in regulating CDK inhibitors Dacapo/p27Kip1 and cyclin E degradation. Cell Cycle 5:71-77.[Medline]
26. Hu, J., C. M. McCall, T. Ohta, and Y. Xiong. 2004. Targeted ubiquitination of CDT1 by the DDB1-CUL4A-ROC1 ligase in response to DNA damage. Nat. Cell Biol. 6:1003-1009.[CrossRef][Medline]
27. Hu, J., and Y. Xiong. 2006. An evolutionarily conserved function of proliferating cell nuclear antigen for Cdt1 degradation by the Cul4-Ddb1 ubiquitin ligase in response to DNA damage. J. Biol. Chem. 281:3753-3756.
28. Huang, H., K. M. Regan, F. Wang, D. Wang, D. I. Smith, J. M. van Deursen, and D. J. Tindall. 2005. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc. Natl. Acad. Sci. USA. 102:1649-1654.
29. James, P., J. Halladay, and E. A. Craig. 1996. Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. Genetics 144:1425-1436.[Abstract]
30. Janssen, K. (ed.). 1995. Current protocols in molecular biology. John Wiley & Sons, Boston, MA.
31. Jiang, H., F. C. Chang, A. E. Ross, J. Lee, K. Nakayama, K. Nakayama, and S. Desiderio. 2005. Ubiquitylation of RAG-2 by Skp2-SCF links destruction of the V(D)J recombinase to the cell cycle. Mol. Cell 18:699-709.[CrossRef][Medline]
32. Jin, J., E. E. Arias, J. Chen, J. W. Harper, and J. C. Walter. 2006. A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1. Mol. Cell 23:709-721.[CrossRef][Medline]
33. Kamath, R. S., M. Martinez-Campos, P. Zipperlen, A. G. Fraser, and J. Ahringer. 2001. Effectiveness of specific RNA-mediated interference through ingested double-stranded RNA in Caenorhabditis elegans. Genome Biol. 2:RESEARCH0002. http://genomebiology.com/2000/2/1/research/0002.[Medline]
34. Keeney, S., G. J. Chang, and S. Linn. 1993. Characterization of a human DNA damage binding protein implicated in xeroderma pigmentosum E. J. Biol. Chem. 268:21293-21300.
35. Kelly, W. G., and A. Fire. 1998. Chromatin silencing and the maintenance of a functional germ line in Caenorhabditis elegans. Development 125:2451-2456.[Abstract]
36. Kondo, T., M. Kobayashi, J. Tanaka, A. Yokoyama, S. Suzuki, N. Kato, M. Onozawa, K. Chiba, S. Hashino, M. Imamura, Y. Minami, N. Minamino, and M. Asaka. 2004. Rapid degradation of Cdt1 upon UV-induced DNA damage is mediated by SCFSkp2 complex. J. Biol. Chem. 279:27315-27319.
37. Koppen, M., J. S. Simske, P. A. Sims, B. L. Firestein, D. H. Hall, A. D. Radice, C. Rongo, and J. D. Hardin. 2001. Cooperative regulation of AJM-1 controls junctional integrity in Caenorhabditis elegans epithelia. Nat. Cell Biol. 3:983-991.[CrossRef][Medline]
38. Lee, C., B. Hong, J. M. Choi, Y. Kim, S. Watanabe, Y. Ishimi, T. Enomoto, S. Tada, Y. Kim, and Y. Cho. 2004. Structural basis for inhibition of the replication licensing factor Cdt1 by geminin. Nature 430:913-917.[CrossRef][Medline]
39. Lehmann, R. 2001. Cell migration in invertebrates: clues from border and distal tip cells. Curr. Opin. Genet. Dev. 11:457-463.[CrossRef][Medline]
40. Li, B., N. Jia, R. Kapur, and K. T. Chun. 2006. Cul-4A targets p27 for degradation and regulates proliferation, cell cycle exit, and differentiation during erythropoiesis. Blood 101:1769-1776.
41. Li, T., X. Chen, K. C. Garbutt, P. Zhou, and N. Zheng. 2006. Structure of DDB1 in complex with a paramyxovirus V protein: viral hijack of a propeller cluster in ubiquitin ligase. Cell 124:105-117.[CrossRef][Medline]
42. Li, X., Q. Zhao, R. Liao, P. Sun, and X. Wu. 2003. The SCF(Skp2) ubiquitin ligase complex interacts with the human replication licensing factor Cdt1 and regulates Cdt1 degradation. J. Biol. Chem. 278:30854-30858.
43. Lin, Y. W., and J. L. Yang. 2006. Cooperation of ERK and SCFSkp2 for MKP-1 destruction provides a positive feedback regulation of proliferating signaling. J. Biol. Chem. 281:915-926.
44. Liu, C., M. Poitelea, A. Watson, S. H. Yoshida, C. Shimoda, C. Holmberg, O. Nielsen, and A. M. Carr. 2005. Transactivation of Schizosaccharomyces pombe cdt2+ stimulates a Pcu4-Ddb1-CSN ubiquitin ligase. EMBO J. 24:3940-3951.[CrossRef][Medline]
45. Liu, C., K. A. Powell, K. Mundt, L. Wu, A. M. Carr, and T. Caspari. 2003. Cop9/signalosome subunits and Pcu4 regulate ribonucleotide reductase by both checkpoint-dependent and -independent mechanisms. Genes Dev. 17:1130-1140.
46. Liu, E., X. Li, F. Yan, Q. Zhao, and X. Wu. 2004. Cyclin-dependent kinases phosphorylate human Cdt1 and induce its degradation. J. Biol. Chem. 279:17283-17288.
47. Machida, Y. J., J. L. Hamlin, and A. Dutta. 2005. Right place, right time, and only once: replication initiation in metazoans. Cell 123:13-24.[CrossRef][Medline]
48. Marti, A., C. Wirbelauer, M. Scheffner, and W. Krek. 1999. Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation. Nat. Cell Biol. 1:14-19.[CrossRef][Medline]
49. Mello, C., and A. Fire. 1995. DNA transformation. Methods Cell Biol. 48:451-482.[Medline]
50. Mendez, J., X. H. Zou-Yang, S. Y. Kim, M. Hidaka, W. P. Tansey, and B. Stillman. 2002. Human origin recogniti